Mary McNamara-Cullinane
Conseiller Juridique Général chez CLEARPOINT NEURO, INC.
Postes actifs de Mary McNamara-Cullinane
Sociétés | Poste | Début | Fin |
---|---|---|---|
CLEARPOINT NEURO, INC. | Conseiller Juridique Général | 08/08/2022 | - |
Historique de carrière de Mary McNamara-Cullinane
Anciens postes connus de Mary McNamara-Cullinane
Sociétés | Poste | Début | Fin |
---|---|---|---|
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Conseiller Juridique Général | - | - |
ECHO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 19/12/2013 | - |
Conseiller Juridique Général | 19/12/2013 | - | |
Corporate Officer/Principal | - | 19/12/2013 |
Formation de Mary McNamara-Cullinane
Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
General Counsel | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CLEARPOINT NEURO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Echo Therapeutics, Inc.
Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
- Bourse
- Insiders
- Mary McNamara-Cullinane
- Expérience